Jacobs & Co’s Novartis NVS Stock Holding History

Jacobs & Co’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$394K	Hold	2,520	–	–	0.03%	106
2026 Q1	$384K	Sell	2,520 -80	-3%	-$12.3K	0.04%	104
2025 Q4	$358K	Hold	2,600	–	–	0.03%	104
2025 Q3	$333K	Hold	2,600	–	–	0.03%	104
2025 Q2	$314K	Hold	2,600	–	–	0.03%	108
2025 Q1	$289K	Sell	2,600 -150	-5%	-$16K	0.03%	107
2024 Q4	$267K	Hold	2,750	–	–	0.03%	112
2024 Q3	$316K	Hold	2,750	–	–	0.03%	112
2024 Q2	$292K	Hold	2,750	–	–	0.03%	112
2024 Q1	$266K	Sell	2,750 -225	-8%	-$23.1K	0.03%	114
2023 Q4	$300K	Buy	2,975 +150	+5%	+$14.5K	0.03%	110
2023 Q3	$287K	Hold	2,825	–	–	0.04%	108
2023 Q2	$285K	Hold	2,825	–	–	0.03%	110
2023 Q1	$259K	Hold	2,825	–	–	0.03%	115
2022 Q4	$256K	Hold	2,825	–	–	0.03%	117
2022 Q3	$214K	Hold	2,825	–	–	0.03%	119
2022 Q2	$238K	Sell	2,825 -1,500	-35%	-$132K	0.03%	110
2022 Q1	$379K	Sell	4,325 -1,000	-19%	-$86.6K	0.04%	99
2021 Q4	$465K	Hold	5,325	–	–	0.05%	99
2021 Q3	$435K	Hold	5,325	–	–	0.05%	97
2021 Q2	$485K	Buy	5,325 +600	+13%	+$53.4K	0.06%	94
2021 Q1	$403K	Hold	4,725	–	–	0.05%	95
2020 Q4	$446K	Hold	4,725	–	–	0.06%	93
2020 Q3	$410K	Hold	4,725	–	–	0.06%	91
2020 Q2	$412K	Hold	4,725	–	–	0.07%	92
2020 Q1	$389K	Hold	4,725	–	–	0.08%	97
2019 Q4	$447K	Buy	4,725 +1,500	+47%	+$135K	0.07%	100
2019 Q3	$280K	Hold	3,225	–	–	0.05%	118
2019 Q2	$294K	Sell	3,225 -374	-10%	-$31.7K	0.05%	119
2019 Q1	$310K	Sell	3,599 -279	-7%	-$22.4K	0.05%	120
2018 Q4	$298K	Hold	3,878	–	–	0.06%	109
2018 Q3	$299K	Hold	3,878	–	–	0.05%	111
2018 Q2	$262K	Hold	3,878	–	–	0.05%	114
2018 Q1	$280K	Hold	3,878	–	–	0.05%	111
2017 Q4	$291K	Hold	3,878	–	–	0.05%	110
2017 Q3	$298K	Sell	3,878 -558	-13%	-$42.1K	0.06%	108
2017 Q2	$331K	Sell	4,436 -279	-6%	-$19.8K	0.07%	108
2017 Q1	$313K	Sell	4,715 -1,116	-19%	-$74.4K	0.06%	110
2016 Q4	$380K	Sell	5,831 -508	-8%	-$33K	0.08%	104
2016 Q3	$448K	Hold	6,339	–	–	0.1%	102
2016 Q2	$468K	Hold	6,339	–	–	0.11%	100
2016 Q1	$411K	Hold	6,339	–	–	0.1%	109
2015 Q4	$467K	Sell	6,339 -469	-7%	-$37.3K	0.12%	104
2015 Q3	$560K	Sell	6,808 -558	-8%	-$49.7K	0.15%	102
2015 Q2	$649K	Sell	7,366 -1,277	-15%	-$117K	0.16%	102
2015 Q1	$763K	Sell	8,643 -307	-3%	-$27.2K	0.19%	98
2014 Q4	$743K	Hold	8,950	–	–	0.2%	97
2014 Q3	$755K	Hold	8,950	–	–	0.21%	96
2014 Q2	$726K	Sell	8,950 -514	-5%	-$40.4K	0.21%	95
2014 Q1	$721K	Buy	9,464 +1,116	+13%	+$81.3K	0.22%	94
2013 Q4	$601K	Hold	8,348	–	–	0.19%	96
2013 Q3	$573K	Sell	8,348 -1,339	-14%	-$88.6K	0.2%	93
2013 Q2	$613K	Buy	+9,687	New	+$630K	0.22%	93

Other funds holding NVS

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

GGI

Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Jacobs & Co's NVS Position: Q2 2026 in Review

Jacobs & Co held its Novartis (NVS) position steady in Q2 2026 at 2,520 shares worth $394K. The position accounts for 0.03% of the portfolio, ranked #106.

Jacobs & Co first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $763K in Q1 2015. 734 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Jacobs & Co held 2,520 shares of Novartis worth $394K as of Q2 2026.
Jacobs & Co left its Novartis share count unchanged in Q2 2026.
Novartis made up 0.03% of Jacobs & Co's portfolio in Q2 2026, its #106 holding.
Jacobs & Co first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
Jacobs & Co's Novartis position peaked at $763K in Q1 2015.
734 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.